Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Pulmonology
•
Pulmonary Vascular Disease
What patient related factors and hemodynamic parameters would lead you to avoid transbronchial biopsies in patients with pulmonary hypertension?
Answer from: at Community Practice
I try to avoid if INR is > 1.7 or platelet count is less than 30,000 in patients who have Grp I PAH.
Sign in or Register to read more
14421
Related Questions
Do you use anticoagulants in the management of patients with pulmonary veno-occlusive disease (PVOD)?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
How do you manage concurrent nonlife-threatening hemoptysis and acute pulmonary embolism?
How do you follow pulmonary embolism patients who have completed anticoagulation?
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
How would you approach a pulmonary-renal PR3+ ANCA vasculitis patient who has persistent re-narrowing of mainstem bronchus after several dilatation and stenting procedures, with other anca features well-controlled on rituximab & avacopan?
When do you consider the use of PH specific therapies in patients with pre-capillary pulmonary hypertension associated with sickle cell disease?
In cases of intermediate-risk pulmonary embolism, what factors influence your decision to pursue catheter-directed thrombolysis?
How do you risk stratify patients with different WHO groups of pulmonary hypertension prior to non-cardiac surgeries?
Have you noticed poor response to Tyvaso DPI compared to the nebulized form in PH-ILD?